STOCK TITAN

Evolv Technologies Holdings, Inc. Warrant (EVLVW) Financials

EVLVW
Trailing 12 months to March 31, 2026
Revenue $160.2M +40.9% YoY
Net Income -$36.5M +17.9% YoY
EPS (Diluted) -$0.20 FY2025 annual
Operating Cash Flow $18.0M +204.6% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EVLVW SEC filings page.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) reported $160.2M in revenue over the twelve months to Mar 31, 2026, up 40.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EVLVW FY2025

Revenue is scaling, but gross-margin slippage and persistent operating losses show growth has not yet covered the cost structure.

Cash generation and accounting earnings diverged in FY2025: operating cash flow reached $18.7M while the company reported a net loss of $33.1M. Depreciation and amortization of $24.3M helps explain much of that gap, indicating the cash result benefited materially from noncash expense rather than profitability alone.

Revenue reached $145.9M in FY2025, while gross margin eased to 51.6% from 57.3% in FY2024, so growth did not come with steadily improving unit economics. Operating margin nevertheless improved from -79.2% to -33.2%, implying that scale and lower operating spending relative to revenue reduced losses more than gross-margin expansion did.

Liabilities rose from $150.4M in FY2024 to $185.0M in FY2025, making the balance sheet more dependent on obligations even as operations improved. A current ratio of 1.2x alongside debt-to-equity of 0.2x points to thinner short-term coverage and a newly leveraged capital structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 44 / 100
Financial Health Score 44/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Evolv Technologies Holdings, Inc. Warrant's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
0

Not available for Evolv Technologies Holdings, Inc. Warrant, and counted as zero in the overall score.

Dilution
53

Evolv Technologies Holdings, Inc. Warrant had 175M shares outstanding at the end of fiscal year 2025, against 160M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Evolv Technologies Holdings, Inc. Warrant scores 53/100 among other emerging companies.

R&D Intensity
37

Evolv Technologies Holdings, Inc. Warrant spent $20.6M on research and development in fiscal year 2025, which was 10.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Evolv Technologies Holdings, Inc. Warrant scores 37/100 among other emerging companies.

Revenue Progress
74

Evolv Technologies Holdings, Inc. Warrant reported revenue of $145.9M in fiscal year 2025, against $103.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Evolv Technologies Holdings, Inc. Warrant scores 74/100 among other emerging companies.

Burn Trend
97

Evolv Technologies Holdings, Inc. Warrant's operations generated $18.7M of cash in fiscal year 2025, against $30.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Evolv Technologies Holdings, Inc. Warrant scores 97/100 among other emerging companies.

Balance Sheet
0

Not available for Evolv Technologies Holdings, Inc. Warrant, and counted as zero in the overall score.

Piotroski F-Score Neutral
4/9

Evolv Technologies Holdings, Inc. Warrant passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

Evolv Technologies Holdings, Inc. Warrant reported a net loss of $33.1M while generating $18.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Evolv Technologies Holdings, Inc. Warrant reported an operating loss of $48.5M against $1.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$46.3M
YoY+44.7%
QoQ+20.3%
5Y CAGR+65.8%

Evolv Technologies Holdings, Inc. Warrant generated $46.3M in revenue in Q1 2026. This represents an increase of 44.7% from the same quarter a year earlier. Against the prior quarter it is up 20.3%.

EBITDA
-$1.7M
YoY+81.1%
QoQ-13.3%

Evolv Technologies Holdings, Inc. Warrant's EBITDA was -$1.7M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 81.1% from the same quarter a year earlier. Against the prior quarter it is down 13.3%.

Net Income
-$5.0M
YoY-196.6%
QoQ-146.0%

Evolv Technologies Holdings, Inc. Warrant reported -$5.0M in net income in Q1 2026. This represents a decrease of 196.6% from the same quarter a year earlier. Against the prior quarter it is down 146.0%.

EPS (Diluted)
-$0.03
YoY-200.0%

Evolv Technologies Holdings, Inc. Warrant earned -$0.03 per diluted share (EPS) in Q1 2026. This represents a decrease of 200.0% from the same quarter a year earlier.

Cash & Balance Sheet

Cash & Debt
$56.1M
YoY+123.5%
QoQ+14.1%
5Y CAGR+20.4%

Evolv Technologies Holdings, Inc. Warrant held $56.1M in cash against $28.7M in long-term debt as of Q1 2026.

Shares Outstanding
179M
YoY+9.7%
QoQ+2.3%

Evolv Technologies Holdings, Inc. Warrant had 179M shares outstanding in Q1 2026. This represents an increase of 9.7% from the same quarter a year earlier. Against the prior quarter it is up 2.3%.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin
50.9%
YoY-8.9pp
QoQ+2.6pp
5Y change+38.8pp

Evolv Technologies Holdings, Inc. Warrant's gross margin was 50.9% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 8.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.6 percentage points.

Operating Margin
-18.3%
YoY+26.7pp
QoQ+2.4pp

Evolv Technologies Holdings, Inc. Warrant's operating margin was -18.3% in Q1 2026, reflecting core business profitability. This is up 26.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.

Net Margin
-10.8%
YoY-5.5pp
QoQ-39.1pp

Evolv Technologies Holdings, Inc. Warrant's net profit margin was -10.8% in Q1 2026, showing the share of revenue converted to profit. This is down 5.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 39.1 percentage points.

Return on Equity
-4.2%
YoY-2.8pp
QoQ-13.3pp

Evolv Technologies Holdings, Inc. Warrant's ROE was -4.2% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 13.3 percentage points.

Capital Allocation

R&D Spending
$5.9M
YoY+21.0%
QoQ+8.7%

Evolv Technologies Holdings, Inc. Warrant invested $5.9M in research and development in Q1 2026. This represents an increase of 21.0% from the same quarter a year earlier. Against the prior quarter it is up 8.7%.

Share Buybacks

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

EVLVW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLVW quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24Q3'2410-QQ2'2410-Q
Revenue$46.3M+44.7%$38.5M+32.3%$42.9M+56.6%$32.5M+29.0%$32.0M+44.3%$29.1M+41.4%$27.4M+37.1%$25.2M+33.4%
Cost of Revenue$22.7M+76.8%$19.9M+60.8%$21.5M+86.5%$16.3M+56.0%$12.9M+28.2%$12.4M+12.2%$11.6M+27.4%$10.5M-12.7%
Gross Profit$23.6M+23.2%$18.6M+11.3%$21.3M+34.8%$16.2M+9.9%$19.1M+57.5%$16.7M+75.1%$15.8M+45.2%$14.8M+113.4%
R&D Expenses$5.9M+21.0%$5.4M+0.4%$5.6M-3.5%$4.7M-19.0%$4.9M-24.0%$5.4M-14.5%$5.8M-9.0%$5.8M-8.4%
SG&A Expenses$13.5M-9.7%$10.1M-39.9%$12.6M-10.0%$17.2M+22.6%$15.0M+26.8%$16.8M+50.6%$14.0M+24.1%$14.1M+29.4%
Operating Income-$8.5M+41.1%-$8.0M+57.7%-$8.6M+55.1%-$17.5M+21.8%-$14.4M+34.3%-$18.9M+15.0%-$19.2M+9.6%-$22.4M+7.1%
EBITDA-$1.7M+81.1%-$1.5M-$2.1M+85.6%-$11.7M+36.7%-$8.9M+52.0%N/A-$14.6M+21.7%-$18.5M+15.2%
Interest Expense$962K+96100.0%$1.0M$713K$0$1KN/A$0$0
Income Tax-$37K-158.7%$0$0-$1K$63KN/A$0$0
Net Income-$5.0M-196.6%$10.9M+169.2%-$1.8M+94.1%-$40.5M-1285.9%-$1.7M+85.0%-$15.7M+8.6%-$30.4M-703.3%$3.4M+105.1%
EPS (Basic)-$0.03-200.0%N/A-$0.01+94.7%-$0.25-1350.0%-$0.01+85.7%N/A-$0.19-733.3%$0.02+104.4%
EPS (Diluted)-$0.03-200.0%N/A-$0.01+94.7%-$0.25-1350.0%-$0.01+85.7%N/A-$0.19-733.3%$0.02+104.4%
Diluted Shares (Avg)177M+10.1%N/A173M+9.6%165M-3.7%161M+5.1%N/A158M-9.4%172M+15.2%

EVLVW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLVW quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24Q3'2410-QQ2'2410-Q
Total Assets$304.6M+19.0%$304.4M+13.6%$304.3M+9.3%$280.4M+4.2%$256.0M-8.6%$268.1M-9.8%$278.5M-8.5%$269.1M-11.0%
Current Assets$152.0M+46.5%$151.3M+24.6%$151.6M+12.8%$133.1M-3.1%$103.8M-24.9%$121.4M-29.9%$134.4M-32.5%$137.3M-34.7%
Cash & Equivalents$56.1M+123.5%$49.1M+32.8%$31.5M-31.6%$36.9M+3.5%$25.1M-43.7%$37.0M-44.9%$46.0M-53.8%$35.7M-71.6%
Inventory$8.3M-17.9%$9.3M-45.1%$8.8M-46.1%$12.1M-36.5%$10.1M-12.7%$17.0M+64.0%$16.3M+100.0%$19.1M+236.2%
Accounts Receivable$42.7M+23.9%$30.8M+8.6%$48.9M+40.2%$41.8M+18.0%$34.5M+75.4%$28.4M+31.8%$34.9M+27.5%$35.4M+35.5%
Total Liabilities$184.0M+36.4%$185.0M+23.0%$202.1M+35.2%$187.8M+59.3%$134.9M-3.8%$150.4M-1.7%$149.5M-0.1%$117.8M-26.0%
Current Liabilities$125.9M+33.3%$123.0M+27.2%$119.3M+33.4%$142.9M+78.4%$94.4M+23.6%$96.7M+19.0%$89.5M+20.2%$80.1M+34.0%
Non-Current Liabilities$58.1M+43.4%$62.0M+15.5%$82.7M+37.8%$44.9M+18.9%$40.5M-36.5%$53.7M-25.1%$60.0M-20.3%$37.8M-62.0%
Long-Term Debt$28.7M$28.6M$28.5MN/AN/A$0N/AN/A
Total Equity$120.7M-0.3%$119.4M+1.5%$102.2M-20.7%$92.7M-38.7%$121.1M-13.4%$117.7M-18.4%$129.0M-16.6%$151.2M+5.6%
Retained Earnings-$392.8M-10.2%-$387.8M-9.3%-$398.7M-17.6%-$396.9M-28.7%-$356.4M-14.2%-$354.7M-18.0%-$338.9M-19.6%-$308.5M-6.9%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill.

EVLVW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLVW quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24Q3'2410-QQ2'2410-Q
Operating Cash Flow-$3.2M-25.2%$15.6M+386.0%$3.5M-4.1%$2.1M+109.8%-$2.5M+84.3%$3.2M+201.9%$3.7M+75.3%-$21.6M-305.6%
Depreciation & Amortization$6.8M+23.0%$6.5M$6.5M+41.3%$5.8M+48.7%$5.5M+60.0%N/A$4.6M+76.9%$3.9M+69.6%
Stock-Based Compensation$5.6M+14.5%N/A$5.4M-28.2%$5.5M-25.3%$4.9M-24.1%N/A$7.5M+24.4%$7.4M+11.0%
Investing Cash Flow$9.8M+204.3%$1.4M+110.6%-$39.6M-735.8%$5.8M-53.4%-$9.4M-39.3%-$13.3M+56.3%$6.2M+121.7%$12.3M+124.6%
Financing Cash Flow$322K+1510.0%$679K+3.2%$30.6M+5847.0%$4.1M+1120.1%$20K-93.4%$658K+1165.4%$515K+89.3%$334K+7.4%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

EVLVW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EVLVW quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24Q3'2410-QQ2'2410-Q
Gross Margin50.9%-8.9pp48.4%-9.2pp49.7%-8.1pp49.8%-8.7pp59.8%+5.0pp57.5%+11.1pp57.8%+3.2pp58.5%+21.9pp
Operating Margin-18.3%+26.7pp-20.7%+44.1pp-20.1%+49.9pp-53.8%+34.9pp-45.0%+53.8pp-64.9%-70.0%-88.7%
Net Margin-10.8%-5.5pp28.3%+82.3pp-4.2%-124.6%-5.3%+45.5pp-54.0%+29.5pp-111.3%13.6%
Return on Equity-4.2%-2.8pp9.1%+22.5pp-1.8%+21.8pp-43.8%-46.0pp-1.4%+6.7pp-13.4%-1.4pp-23.6%-26.9pp2.3%+49.2pp
Return on Assets-1.6%-1.0pp3.6%+9.4pp-0.6%+10.3pp-14.4%-15.7pp-0.7%+3.4pp-5.9%-0.1pp-10.9%-12.6pp1.3%+23.5pp
Current Ratio1.21+0.1x1.230.0x1.27-0.2x0.93-0.8x1.10-0.7x1.26-0.9x1.50-1.2x1.71-1.8x
Debt-to-Equity0.24-0.9x0.24+0.2x0.28-0.9x2.03+1.2x1.11+0.1x0.000.0x1.16+1.2x0.78+0.8x
Asset Turnover0.150.0x0.130.0x0.140.0x0.120.0x0.130.0x0.110.0x0.100.0x0.090.0x

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Frequently Asked Questions

What is Evolv Technologies Holdings, Inc. Warrant's annual revenue?

Evolv Technologies Holdings, Inc. Warrant (EVLVW) reported $145.9M in total revenue for fiscal year 2025. This represents a 40.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Evolv Technologies Holdings, Inc. Warrant's revenue growing?

Evolv Technologies Holdings, Inc. Warrant (EVLVW) revenue grew by 40.5% year-over-year, from $103.9M to $145.9M in fiscal year 2025.

Is Evolv Technologies Holdings, Inc. Warrant profitable?

No, Evolv Technologies Holdings, Inc. Warrant (EVLVW) reported a net income of -$33.1M in fiscal year 2025, with a net profit margin of -22.7%.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) reported diluted earnings per share of -$0.20 for fiscal year 2025. This represents a 41.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had EBITDA of -$24.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Evolv Technologies Holdings, Inc. Warrant (EVLVW) had $49.1M in cash and equivalents against $28.6M in long-term debt.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had a gross margin of 51.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had an operating margin of -33.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had a net profit margin of -22.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) has a return on equity of -27.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) generated $18.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had $304.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) invested $20.6M in research and development during fiscal year 2025.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had 175M shares outstanding as of fiscal year 2025.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had a current ratio of 1.23 as of fiscal year 2025, which is considered adequate.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) had a return on assets of -10.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) reported a net loss of $33.1M while generating $18.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) reported an operating loss of $48.5M against $1.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Evolv Technologies Holdings, Inc. Warrant (EVLVW) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top